The downward trend in incidence parallels increased life expectancy among infected patients stabilized with HAART. However, a new study finds that not all populations are equally affected.
A recent study uses results of advanced coronary vessel imaging to compare the presence and extent of subclinical atherosclerosis in HIV-infected and non-infected men.
Prevention counseling has been shown to reduce sexual risk-taking among HIV-infected patients. A new study shows, however, that very few of the highest-risk patients receive intervention.
Treatment for HIV infection initiated within 3 months of diagnosis can shorten time to viral suppression, a new study finds.
These presentations provided a wealth of data suggesting that very early treatment of HIV may help control viremia and achieve remission over time in pediatric patients.
Here: 4 subgroups of HIV patients whose cardiovascular health might benefit from your targeted intervention.
Useful details here about HIV and age-related issues, sexual dysfunction, heart disease, and end-organ damage.
These suggestions will enhance your enjoyment of long meetings and will have your colleagues remarking on what a jolly, friendly person you really are. Ignore the advice at your own peril.
The good: this premier HIV conference offers a banquet of exceptional material. The bad: the expense and the grind of covering a meeting this rich—and lengthy.
Two studies demonstrate that raltegravir is an extremely well-tolerated and potent component of a combination antiretroviral regimen.